Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of 4 Dose Regimens of Oral Albaconazole in Subjects With Distal Subungual Onychomycosis
This study has been completed.
Study NCT00730405   Information provided by GlaxoSmithKline

First Received on August 4, 2008.   Last Updated on August 9, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Onychomycosis
More general conditions related to this trial
Dermatomycoses
Infection
Mycoses
Nail Diseases
Skin Diseases
Skin Diseases, Infectious
Tinea
Interventions listed in this trial
Albaconazole 100mg
Albaconazole 200mg
Albaconazole 400mg
Placebo 400 mg
Sponsors listed in this trial
Stiefel, a GSK Company
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services